Demand For Gene Therapy Is Projected To Exceed $18.72 Billion By 2031


THE GLOBAL GENE THERAPY MARKET IS EXPECTED TO GROW BY 19.3% YEAR-ON-YEAR , FROM $1.55 BILLION IN 2021 TO $1.85 BILLION IN 2022. FROM 2022 TO 2032, THE MARKET IS POISED TO REACH A VALUE OF US$ 10.1 BILLION, REGISTERING A CAGR OF 18.5% .

KEY MARKET METRICS AND FORECASTS FOR THE NEXT FEW YEARS ARE PROVIDED BY THE GENE THERAPY STUDY. IN-DEPTH COVERAGE OF PERTINENT DATA AND STATISTICS IS PROVIDED IN THIS STUDY. ADDITIONALLY, VISUAL AIDS LIKE GRAPHS, TABLES, AND DIAGRAMS IMPROVED THE CONTENT AND MADE IT SIMPLER FOR READERS TO READ. FOR THOROUGH RESEARCH INSIGHTS, FACTMR’S RESEARCH TEAM, ANALYSTS, AND CONSULTANTS COVER A WIDER RANGE OF INDUSTRIES AND NATIONS. GENE THERAPY MANUFACTURERS ARE INTENDED TO BE HELPED BY INFORMATION ON MARKET OPPORTUNITIES, DRIVERS, CHALLENGES, AND THREATS TO EITHER MINIMIZE OR MAXIMIZE THEIR BUSINESS OPERATIONS.

DOWNLOAD SAMPLE COPY OF THIS REPORT :- HTTPS://WWW.FACTMR.COM/CONNECTUS/SAMPLE?FLAG=S&REP_ID=4648

WHAT ARE THE DRIVING DEMAND FOR GENE THERAPY ?

INCREASING PREVALENCE OF GENETIC DISEASES: THE INCREASING PREVALENCE OF GENETIC DISEASES IS DRIVING THE DEMAND FOR GENE THERAPY.
GROWING AWARENESS OF GENE THERAPY: GROWING AWARENESS OF GENE THERAPY AND ITS POTENTIAL TO TREAT GENETIC DISEASES IS DRIVING THE DEMAND FOR GENE THERAPY.
TECHNOLOGICAL ADVANCEMENTS: TECHNOLOGICAL ADVANCEMENTS IN GENE THERAPY ARE DRIVING THE DEMAND FOR GENE THERAPY.
INCREASING INVESTMENTS IN GENE THERAPY: INCREASING INVESTMENTS IN GENE THERAPY RESEARCH AND DEVELOPMENT ARE DRIVING THE DEMAND FOR GENE THERAPY.
GROWING DEMAND FOR PERSONALIZED MEDICINE: THE GROWING DEMAND FOR PERSONALIZED MEDICINE IS DRIVING THE DEMAND FOR GENE THERAPY.
MAIN SECTORS COVERED

PRODUCT
YEKARTA
WALES
LUTURNA
STREAM BELLIS
GENDYSIN
APPLICATION
OPHTHALMOLOGY
ONCOLOGY
ADENOSINE DEAMINASE/SEVERE COMBINED IMMUNODEFICIENCY (ADA-SCID)
NEED MORE INFORMATION ABOUT OUR REPORTING METHODOLOGY? CLICK HERE:- HTTPS://WWW.FACTMR.COM/CONNECTUS/SAMPLE?FLAG=RM&REP_ID=4648

KEY GENE THERAPY PROVIDERS

NOVARTIS AG
GILEAD SCIENCES INC.
SPARK THERAPEUTICS INC.
SIBIONO GENETECH CO. LTD.
CELGENE CORPORATION
ORCHARD THERAPEUTICS LIMITED
BIONTECH
SOME OF THE EFFECTIVE GENE THERAPY INSIGHTS AND ESTIMATES THAT MAKE THIS STUDY UNIQUE IN ITS APPROACH AND GUIDE STAKEHOLDERS IN UNDERSTANDING GROWTH DYNAMICS. THIS STUDY INCLUDES:

DETAILS ON THE LATEST INNOVATIONS AND DEVELOPMENTS IN GENE THERAPY AND HOW TO ENGAGE CUSTOMERS DURING THE FORECAST PERIOD.
ANALYSIS OF CUSTOMER DEMAND FOR THE PRODUCT AND HOW IT IS LIKELY TO DEVELOP IN THE COMING YEARS.
THE LATEST REGULATIONS IMPLEMENTED BY GOVERNMENT AGENCIES AND LOCAL AGENCIES AND THEIR IMPACT ON DEMAND FOR GENE THERAPY.
INSIGHTS INTO THE ADOPTION OF NEW TECHNOLOGIES AND THEIR IMPACT ON THE GENE THERAPY MARKET SIZE.
AN OVERVIEW OF THE IMPACT OF COVID-19 ON GENE THERAPY AND THE ECONOMIC DISRUPTION CAUSED BY THE PANDEMIC.
EVALUATE THE POST-PANDEMIC IMPACT ON GENE THERAPY SALES OVER THE FORECAST PERIOD.
GET FULL ACCESS TO THIS PREMIUM REPORT: – HTTPS://WWW.FACTMR.COM/CHECKOUT/4648

AFTER READING THE GENE THERAPY REPORT MARKET INSIGHTS, READERS MAY:

UNDERSTAND THE DRIVERS, CONSTRAINTS, OPPORTUNITIES AND TRENDS AFFECTING MARKET SALES.
TO ANALYZE THE MAJOR REGIONS THAT ACCOUNT FOR A SIGNIFICANT SHARE IN THE TOTAL REVENUE OF THE GENE THERAPY MARKET.
STUDY THE GROWTH PROSPECTS OF THE GENE THERAPY MARKET SCENARIO, INCLUDING PRODUCTION, CONSUMPTION, HISTORY, AND FORECAST.
LEARN ABOUT CONSUMPTION PATTERNS AND IMPACT OF EACH ANALYSIS ON THE END USE AND SUPPLY SIDE OF THE GENE THERAPY MARKET.
INVESTIGATE RECENT R&D PROJECTS BY MARKET PLAYER AND COMPETITIVE ANALYSIS OF GENE THERAPY PARTICIPANTS.